SCHEMBL30439034

SCHEMBL30439034

COc1nc(S(=O)(=O)N2CCCNCC2CCC(C)C)cc2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 3/20 0.35
▸ MMP9 P14780 3/20 0.35
▸ MMP13 P45452 3/20 0.35
▸ HTR7 P34969 5/20 0.35
▸ ROCK2 O75116 4/20 0.35
▸ ROCK1 Q13464 4/20 0.35
▸ PRKACA P17612 4/20 0.35
▸ PRKCD Q05655 4/20 0.35
▸ HTR1D P28221 3/20 0.35
▸ HTR2B P41595 3/20 0.35
▸ PRKD3 O94806 3/20 0.35
▸ PRKCZ Q05513 3/20 0.35
▸ PRKACG P22612 3/20 0.35
▸ PRKACB P22694 3/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ DRD2 P14416 2/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ PLK4 O00444 2/20 0.35
▸ MARK3 P27448 2/20 0.35
▸ PRKAA1 Q13131 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30438744 0.88 MMP1 (0.38) MMP1MMP9MMP13HTR7ROCK2
SCHEMBL30438695 0.80 ROCK1 (0.41) HTR7ROCK2ROCK1PRKACAPRKCD
SCHEMBL23795358 0.80 ROCK1 (0.41) HTR7ROCK2ROCK1PRKACAPRKCD
SCHEMBL23795329 0.80 ROCK1 (0.41) HTR7ROCK2ROCK1PRKACAPRKCD
SCHEMBL30439149 0.80 MMP1 (0.45) MMP1MMP9MMP13HTR7HTR1D
SCHEMBL30439065 0.76 TAAR1 (0.43) MMP1MMP9MMP13HTR7ROCK2
SCHEMBL30438733 0.73 ROCK2 (0.38) MMP1MMP9MMP13HTR7ROCK2
SCHEMBL30439166 0.70 MMP1 (0.47) MMP1MMP9MMP13HTR6
SCHEMBL30439345 0.70 ROCK2 (0.51) MMP1MMP9MMP13HTR7ROCK2
SCHEMBL23795312 0.69 ROCK1 (0.42) HTR7ROCK2ROCK1PRKACAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback